Vimarsana
Biggest News Aggregation in the World

Page 23 - Aadi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aadi Bioscience Today - Breaking & Trending Today

Life sciences industry drives activity in Q2 office market - Vimarsana News

Life sciences industry drives activity in Q2 office market

Office leasing gained some in Q2, seeing 2.8 million square feet of activity, according to Colliers, driven by life sciences.

Source: njbiz.com
Aadi Bioscience, Inc. (NASDAQ:AADI) Given Consensus Recommendation of "Buy" by Brokerages - Vimarsana News

Aadi Bioscience, Inc. (NASDAQ:AADI) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) have been assigned a consensus rating of “Buy” from the six research firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price […]

Aadi Bioscience Appoints Marcy Graham Senior Vice President - Vimarsana News

Aadi Bioscience Appoints Marcy Graham Senior Vice President

LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing...

Aadi Bioscience Announces Exploratory Biomarker Data from - Vimarsana News

Aadi Bioscience Announces Exploratory Biomarker Data from

Target tumor reductions observed in advanced malignant PEComa patients harboring TSC1 or TSC2 inactivating alterations regardless of prior mTOR inhibitor...

Aadi Bioscience (NASDAQ:AADI) Posts Earnings Results, Beats Estimates By $0.02 EPS - Vimarsana News

Aadi Bioscience (NASDAQ:AADI) Posts Earnings Results, Beats Estimates By $0.02 EPS

Aadi Bioscience (NASDAQ:AADI – Get Rating) announced its quarterly earnings results on Thursday. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.68) by $0.02, MarketWatch Earnings reports. During the same quarter in the previous year, the firm posted ($0.90) EPS. Shares of Aadi Bioscience stock opened at […]